This protocol addresses the management of seborrheic dermatitis (SD) in a patient with HIV infection. In this population, SD is generally not only more prevalent but also more severe than in the general population, and it frequently follows a relapsing course.
Management in this setting involves topical antifungal therapy applied on a defined schedule. The structured regimen specifies the agent, frequency, and duration — along with maintenance considerations.
DOI: 10.2147/CCID.S284671
In HIV-infected patients, SD is generally not only more prevalent but also more severe than usual, and frequently associated to a relapsing course.
Mild SD forms, in either children or adults, may be treated with topical 2% ketoconazole, two to three times per week for 4 weeks, with a once weekly maintenance treatment as needed.
View source ↗